{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:13:01Z","timestamp":1773810781706,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Sichuan University West China Hospital Clinical Incubation 1.3.5 Project","award":["2022HXFH002"],"award-info":[{"award-number":["2022HXFH002"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82173182"],"award-info":[{"award-number":["82173182"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-025-03106-y","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T11:34:00Z","timestamp":1737200040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Medical thoracoscopy combined with intrapleural injection of urokinase for treatment of pleural infection-a multicenter, prospective, randomized controlled study: study protocol"],"prefix":"10.1186","volume":"26","author":[{"given":"Kaige","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linhui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panwen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,18]]},"reference":[{"key":"3106_CR1","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.chest.2021.05.026","volume":"160","author":"SR Mummadi","year":"2021","unstructured":"Mummadi SR, Stoller JK, Lopez R, Kailasam K, Gillespie CT, Hahn PY. Epidemiology of adult pleural disease in the United States. Chest. 2021;160:1534\u201351.","journal-title":"Chest"},{"key":"3106_CR2","doi-asserted-by":"publisher","first-page":"e2120306","DOI":"10.1001\/jamanetworkopen.2021.20306","volume":"4","author":"P Tian","year":"2021","unstructured":"Tian P, Qiu R, Wang M, et al. Prevalence, causes, and health care burden of pleural effusions among hospitalized adults in China. JAMA Netw open. 2021;4:e2120306.","journal-title":"JAMA Netw open"},{"key":"3106_CR3","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1164\/ajrccm\/148.3.813","volume":"148","author":"SA Sahn","year":"1993","unstructured":"Sahn SA. Management of complicated parapneumonic effusions. Am Rev Respir Dis. 1993;148:813\u201317.","journal-title":"Am Rev Respir Dis"},{"key":"3106_CR4","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa1012740","volume":"365","author":"NM Rahman","year":"2011","unstructured":"Rahman NM, Maskell NA, West A, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011;365:518\u201326.","journal-title":"N Engl J Med"},{"key":"3106_CR5","doi-asserted-by":"crossref","unstructured":"B\u00e9dat B, Plojoux J, Noel J et al. Comparison of intrapleural use of urokinase and tissue plasminogen activator\/DNAse in pleural infection. ERJ Open Res. 2019;5.","DOI":"10.1183\/23120541.00084-2019"},{"key":"3106_CR6","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1513\/AnnalsATS.202001-076OC","volume":"17","author":"F Kheir","year":"2020","unstructured":"Kheir F, Thakore S, Mehta H, et al. Intrapleural fibrinolytic therapy versus early medical thoracoscopy for treatment of pleural infection. Randomized Controlled Clinical Trial. Annals Am Thorac Soc. 2020;17:958\u201364.","journal-title":"Annals Am Thorac Soc"},{"key":"3106_CR7","first-page":"46","volume":"102","author":"C Ravaglia","year":"2023","unstructured":"Ravaglia C, Ghirotti C, Puglisi S, et al. Medical thoracoscopy and intrapleural fibrinolytic therapy for the management of pleural empyema: a cohort study. Respir Int Rev Thorac Dis. 2023;102:46\u201354.","journal-title":"Respir Int Rev Thorac Dis"},{"key":"3106_CR8","doi-asserted-by":"crossref","unstructured":"Bedawi EO, Ricciardi S, Hassan M et al. ERS\/ESTS statement on the management of pleural infection in adults. Eur Respir J. 2023;61.","DOI":"10.1183\/13993003.01062-2022"},{"key":"3106_CR9","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1136\/thorax-2023-220304","volume":"78","author":"ME Roberts","year":"2023","unstructured":"Roberts ME, Rahman NM, Maskell NA, et al. British thoracic society guideline for pleural disease. Thorax. 2023;78:1143\u201356.","journal-title":"Thorax"},{"key":"3106_CR10","doi-asserted-by":"crossref","unstructured":"Altmann ES, Crossingham I, Wilson S, Davies HR. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema. The Cochrane database of systematic reviews. 2019;2019.","DOI":"10.1002\/14651858.CD002312.pub4"},{"key":"3106_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12890-023-02559-5","volume":"23","author":"J Taniguchi","year":"2023","unstructured":"Taniguchi J, Matsui H, Nagai T, et al. Association between intrapleural urokinase monotherapy and treatment failure in patients with pleural infection: a retrospective cohort study. BMC Pulm Med. 2023;23:273.","journal-title":"BMC Pulm Med"},{"key":"3106_CR12","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1164\/rccm.202305-0854OC","volume":"208","author":"EO Bedawi","year":"2023","unstructured":"Bedawi EO, Stavroulias D, Hedley E, et al. Early video-assisted thoracoscopic surgery or intrapleural enzyme therapy in pleural infection: a feasibility randomized controlled trial. The third Multicenter Intrapleural Sepsis Trial-MIST-3. Am J Respir Crit Care Med. 2023;208:1305\u201315.","journal-title":"Am J Respir Crit Care Med"},{"key":"3106_CR13","first-page":"85","volume":"66","author":"T Ramasli Gursoy","year":"2020","unstructured":"Ramasli Gursoy T, Sismanlar Eyuboglu T, Onay ZR, et al. Pleural thickening after pleural effusion: how can we follow-up in children? J Trop Pediatr. 2020;66:85\u201394.","journal-title":"J Trop Pediatr"},{"key":"3106_CR14","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.chest.2022.06.008","volume":"162","author":"J Akulian","year":"2022","unstructured":"Akulian J, Bedawi EO, Abbas H, et al. Bleeding risk with combination intrapleural fibrinolytic and enzyme therapy in pleural infection: an international, multicenter, retrospective cohort study. Chest. 2022;162:1384\u201392.","journal-title":"Chest"},{"key":"3106_CR15","doi-asserted-by":"publisher","first-page":"e237799","DOI":"10.1001\/jamanetworkopen.2023.7799","volume":"6","author":"CL Wilshire","year":"2023","unstructured":"Wilshire CL, Jackson AS, Valli\u00e8res E, et al. Effect of intrapleural fibrinolytic therapy vs surgery for complicated pleural infections: a randomized clinical trial. JAMA Netw open. 2023;6:e237799.","journal-title":"JAMA Netw open"},{"key":"3106_CR16","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/resp.14261","volume":"27","author":"N Popowicz","year":"2022","unstructured":"Popowicz N, Ip H, Lau EPM, et al. Alteplase dose assessment for pleural infection therapy (ADAPT) study-2: use of 2.5\u00a0mg alteplase as a starting intrapleural dose. Respirol (Carlton Vic). 2022;27:510\u20136.","journal-title":"Respirol (Carlton Vic)"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03106-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03106-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03106-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T11:34:08Z","timestamp":1737200048000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-025-03106-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,18]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3106"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03106-y","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,18]]},"assertion":[{"value":"16 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Sichuan University West China Hospital Biomedical Ethics Committee (Ethics number: 2023\u2009\u2212\u20091839). All participants will be fully informed of objectives, protocol, and potential risks of the study prior to enrollment, and will provide written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Every human participant should provide their consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}